Farapulse Stock

farapulse.comHealthcareFounded: 1900Funding to Date: $80.75MM

FARAPULSE provides tissue-selective PFA therapy through development and commercialization of its dedicated generator (FARASTAR), PVI-focused catheter (FARAWAVE), large-area focal catheter (FARAFLEX), precision focal catheter (FARAPOINT) and a proprietary deflectable delivery sheath (FARADRIVE).

Register for Details

For more details on financing and valuation for Farapulse, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Allan Zingeler
President, Board Member & Chief Executive Officer

Board Members

Andrew ElBardissi MD
Deerfield Management
Chris Kaster
James Eadie MD
Santé Ventures
Robert Weisskoff Ph.D
F-Prime Capital Partners

Other companies like Farapulse in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$263MM